These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 9323144)

  • 21. Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck: results from a phase III randomized trial.
    Corvò R; Benasso M; Sanguineti G; Lionetto R; Bacigalupo A; Margarino G; Pallestrini E; Merlano M; Vitale V; Rosso R
    Cancer; 2001 Dec; 92(11):2856-67. PubMed ID: 11753959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group.
    Lefebvre JL; Chevalier D; Luboinski B; Kirkpatrick A; Collette L; Sahmoud T
    J Natl Cancer Inst; 1996 Jul; 88(13):890-9. PubMed ID: 8656441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
    Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma.
    Porceddu SV; Campbell B; Rischin D; Corry J; Weih L; Guerrieri M; Grossi M; Peters LJ
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):365-73. PubMed ID: 15380568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer.
    Kovács AF; Mose S; Böttcher HD; Bitter K
    Strahlenther Onkol; 2005 Jan; 181(1):26-34. PubMed ID: 15660190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.
    Bernier J; Domenge C; Ozsahin M; Matuszewska K; Lefèbvre JL; Greiner RH; Giralt J; Maingon P; Rolland F; Bolla M; Cognetti F; Bourhis J; Kirkpatrick A; van Glabbeke M;
    N Engl J Med; 2004 May; 350(19):1945-52. PubMed ID: 15128894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma.
    Urba SG; Forastiere AA; Wolf GT; Esclamado RM; McLaughlin PW; Thornton AF
    J Clin Oncol; 1994 May; 12(5):946-53. PubMed ID: 8164046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck.
    Brizel DM; Leopold KA; Fisher SR; Panella TJ; Fine RL; Bedrosian CL; Kenan PD; Huang A; Womack T; Bjurstrom T
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):213-20. PubMed ID: 8270444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer With hyperfractionated radiation and concurrent chemotherapy.
    Adelstein DJ; Saxton JP; Lavertu P; Rybicki LA; Esclamado RM; Wood BG; Strome M; Carroll MA
    J Clin Oncol; 2002 Mar; 20(5):1405-10. PubMed ID: 11870186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer.
    Taylor SG; Murthy AK; Vannetzel JM; Colin P; Dray M; Caldarelli DD; Shott S; Vokes E; Showel JL; Hutchinson JC
    J Clin Oncol; 1994 Feb; 12(2):385-95. PubMed ID: 8113846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent chemoradiotherapy with low-dose cisplatin plus 5-fluorouracil for the treatment of patients with unresectable head and neck cancer.
    Kohno N; Kitahara S; Tamura E; Tanabe T
    Oncology; 2002; 63(3):226-31. PubMed ID: 12381901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.
    Ghi MG; Paccagnella A; D'Amanzo P; Mione CA; Fasan S; Paro S; Mastromauro C; Carnuccio R; Turcato G; Gatti C; Pallini A; Nascimben O; Biason R; Oniga F; Medici M; Rossi F; Fila G
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):481-7. PubMed ID: 15145166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck.
    Garden AS; Harris J; Vokes EE; Forastiere AA; Ridge JA; Jones C; Horwitz EM; Glisson BS; Nabell L; Cooper JS; Demas W; Gore E
    J Clin Oncol; 2004 Jul; 22(14):2856-64. PubMed ID: 15254053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy.
    Lefebvre JL; Rolland F; Tesselaar M; Bardet E; Leemans CR; Geoffrois L; Hupperets P; Barzan L; de Raucourt D; Chevalier D; Licitra L; Lunghi F; Stupp R; Lacombe D; Bogaerts J; Horiot JC; Bernier J; Vermorken JB; ;
    J Natl Cancer Inst; 2009 Feb; 101(3):142-52. PubMed ID: 19176454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerated fractionation radiotherapy and concomitant chemotherapy in patients with stage IV inoperable head and neck cancer.
    Dragovic J; Doyle TJ; Tilchen EJ; Nichols RD; Benninger MS; Carlson ER; Boyd SB; Jacobsen GR
    Cancer; 1995 Nov; 76(9):1655-61. PubMed ID: 8635071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term results of conventional radiotherapy versus accelerated hyperfractionated radiotherapy versus concomitant radiotherapy and chemotherapy in locoregionally advanced carcinoma of the oropharynx.
    Fallai C; Bolner A; Signor M; Gava A; Franchin G; Ponticelli P; Taino R; Rossi F; Ardizzoia A; Oggionni M; Crispino S; Olmi P
    Tumori; 2006; 92(1):41-54. PubMed ID: 16683383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
    Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.
    Cooper JS; Pajak TF; Forastiere AA; Jacobs J; Campbell BH; Saxman SB; Kish JA; Kim HE; Cmelak AJ; Rotman M; Machtay M; Ensley JF; Chao KS; Schultz CJ; Lee N; Fu KK;
    N Engl J Med; 2004 May; 350(19):1937-44. PubMed ID: 15128893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up on an intensified treatment regimen for advanced resectable head and neck squamous cell carcinomas.
    Grecula JC; Schuller DE; Smith R; Rhoades CA; Nag S; Bauer CJ; Agrawal A; Au JL; Young D; Gahbauer RA
    Cancer Invest; 2001; 19(2):127-36. PubMed ID: 11296617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.